World / Transplantation
23.08.2008 10:31
medicalnewstoday.com
Two men have undergone face transplants -- one after being attacked by a bear and another after suffering from a large facial tumor -- and they have indicated promising results. These cases indicate that the procedure might be used more regularly for long-term restoration of facial disfigurement, and are described in two articles released in The Lancet on August 22, 2008 describe face transplants that were performed in 2006 and 2007 which appear to have promising results.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
A recently published article by Sanchez-Velasco et al. in Clinical Transplantation has expanded our understanding of the clinical potential of monitoring cell-mediated immunity in adult patients at risk for organ rejection or infection subsequent to kidney transplantation.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
A new fun viral campaign with a serious message has been launched to encourage more people to pledge to save a life by signing up as an organ donor. Developed as part of UK Transplant's 'Superhero' campaign 2008, the new game gives users the chance to 'superhero themselves' online with a fun photo application http://www.superhero-me.co.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
LinkMed's (STO:LMED) portfolio company AbSorber recently received FDA approval in the U.S. for its patented transplantation test XM-ONE®. Now AbSorber has received further support for its transplantation test from a major clinical trial in which six well-reputed transplantation centers in the U.S. and Sweden participated.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease. Children's National will join more than 20 other medical institutions in the first-ever Phase II clinical trial of this treatment.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
MicroIslet Inc. (OTCBB: MIIS), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report on the Company's presentation at the XXII International Congress Of The Transplantation Society Meeting, being held August 10-14, 2008, at the Sydney Convention & Exhibition Centre in Sydney, Australia. Drs.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
Music lovers going to this summer's V Festivals are being given the chance to become a 'superhero' and pledge to save a life by signing up as an organ donor. For the first time, the UK Transplant 'Superhero' roadshow will be at both festival venues to encourage music fans to join the NHS Organ Donor Register (ODR). The two-day V Festivals are being staged at Weston Park in Staffordshire and Hylands Park near Chelmsford in Essex on Saturday and Sunday, 16 and 17 August.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
The controversial case of three infant heart transplants performed at a hospital in Denver, USA, has stirred an ethical and legal debate, with one expert suggesting that the criteria used to obtain the organs were not strictly within the law as it applies to the definition of donor death.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
The babies were dying without life support, they might live just another few minutes. Their families had said goodbye, and wanted their newborns to become organ donors, in hopes of saving another tiny life. But the babies' conditions couldn't meet the normal standards for organ donor eligibility.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
All countries should take steps to govern organ donation and transplantation, thereby ensuring patient safety and prohibiting unethical practices, according to an article appearing in the September 2008 issue of the Clinical Journal of the American Society of Nephrology (CJASN).
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the US Food and Drug Administration ("FDA") for the treatment of chronic allograft nephropathy. Chronic allograft nephropathy (CAN), also known as chronic allograft dysfunction, is a fibrotic condition that is a leading cause of kidney transplant failure.
World
Transplantation
23.08.2008 10:31
medicalnewstoday.com
Federal, provincial and territorial ministries of health announced today a combined investment of $35 million over the next five years to create an integrated national system to significantly improve organ donation and transplantation in Canada.
World
Transplantation
23.08.2008 10:30
medicalnewstoday.com
Since Gunther von Hagens' BODY WORLDS 4 opened at Manchester's Museum of Science & Industry (MOSI) on February 22nd this year, 20 more British Body Donors have pledged their bodies for Plastination and educational purposes under a unique body donation programme. The total of British people who have become body donors now stands at 127.
World
Transplantation
23.08.2008 10:30
medicalnewstoday.com
The Swedish biotech company AbSorber has been given clearance by the U.S. Food and Drug Administration (FDA) to market and sell its XM-ONE® transplantation test in the U.S. Initially, sales of XM-ONE® in the U.S. will target the kidney transplantation market valued at approximately SEK 200 million. XM-ONE® previously received CE marking and is approved for sales within the EU.
World
Transplantation
23.08.2008 10:30
medicalnewstoday.com
Data presented at the 22nd International Congress of The Transplantation Society provides further direction to transplant doctors to test the immunosuppression drug levels of patients who are most at risk of rejecting their transplanted organ. The data, a follow-up analysis of the FDCC* study of 901 kidney transplant recipients, shows that the active component in CellCept, mycophenolic acid (MPA), should be measured in 'at risk'** patients.
World
Transplantation
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 01 | 02 | |||||
| 03 | 04 | 05 | 06 | 07 | 08 | 09 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
| 31 | ||||||
English
Українська
Русский
Date: 29 August 2008 - 18:02
Number of sources in English: 130